European journal of haematology

The most recent articles from: Eur. J. Haematol. July 2017

Eur. J. Haematol. · Jul 2017

Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?

The role of allogenic stem cell transplantation (ASCT) is still debated in myelofibrosis (MF). ⋯ Not all intermediate-2/high-risk DIPSS+ MF patients benefit from ASCT, especially since the introduction of JAK2 inhibitors.

read more… or not…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!